Yéssica Plata-Fernández

The Role of Immunohistochemistry in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: An Old Tool With an Enduring Prognostic Value

Alfonso Sánchez‐Muñoz, Yéssica Plata-Fernández, Margarita Fernández et al. · Clinical Breast Cancer · 2013 · 39 citations

Breast Oncology, Breast Cancer Patients, Medicine +10

Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes

Alfonso Sánchez‐Muñoz, Luís Vicioso, Ángela Santonja et al. · Modern Pathology · 2017 · 28 citations · Full text

Pam50 Intrinsic Subtypes, Breast Oncology, Cancer Pathology +9

Proliferation Determined by Ki-67 Defines Different Pathologic Response to Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer

Alfonso Sánchez‐Muñoz, Víctor Navarro-Pérez, Yéssica Plata-Fernández et al. · Clinical Breast Cancer · 2015 · 15 citations

Breast Oncology, Medicine, Pathology +8

Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients

Alfonso Sánchez‐Muñoz, Yéssica Plata-Fernández, A. Jaén-Morago et al. · Clinical & Translational Oncology · 2013 · 13 citations

Breast Oncology, Medicine, Gynecology +9